| Date | Title | Description |
| 18.05.2026 | MiddleGround Capital: Firmwide Promotions Include Roland Veldhuijzen van Zanten Elevated To Managing Director | MiddleGround Capital announced seven firmwide promotions, including the elevation of Roland Veldhuijzen van Zanten to Managing Director, reflecting the private equity firm’s continued growth and focus on developing talent internally.
Veldhu... |
| 22.01.2026 | Exciva Secures €51 Million Series B: Alzheimer's Agitation Therapy Advances to Phase 2 | Exciva closed a €51 million Series B funding round. This financing fuels Deraphan, its Alzheimer's agitation therapy, into crucial Phase 2 trials. EQT Life Sciences and Gimv spearheaded the investment. The global study addresses a pressing ... |
| 20.01.2026 | EQT Life Sciences co-leads EUR 51 million Series B in Exciva to advance its Alzheimer’s therapy into clinical Phase 2 | EQT Life Sciences co-leads EUR 51 million Series B in Exciva to advance its Alzheimer’s therapy into clinical Phase 2
Tue, Jan 20, 2026 07:30 CET Report this content
Series B financing will support Exciva’s Phase 2 clinical trial of its lea... |
| 20.01.2026 | Andera Partners’ Portfolio Company Exciva Secures €51 Million Series B to Advance Clinical Program for Alzheimer’s-Related Agitation. | Andera Partners, a leading European private equity player, today announced that it participated in the €51 million ($59 million) Series B financing round of its portfolio company Exciva GmbH, a biopharmaceutical company developing novel the... |
| 20.01.2026 | Exciva raises €51M in Series B Funding | Exciva, a Heidelberg, Germany-based biopharmaceutical company developing new therapeutic compounds for the treatment of neuropsychiatric conditions, raised €51M in Series B funding.
The round was led by Gimv and EQT Life Sciences. Additiona... |
| 20.01.2026 | German BioTech Exciva lands €51 million to advance Alzheimer’s drug testing in patients | Heidelberg-based Exciva, a biopharmaceutical company developing novel therapeutic compounds for the treatment of neuropsychiatric conditions, today announces the closing of a €51 million ($59 million) Series B round.
Gimv and EQT Life Scien... |
| 20.01.2026 | Exciva: €51 Million Series B Closed To Advance Alzheimer’s Agitation Therapy Into Phase 2 | EQT Life Sciences announced it co-led a €51 million Series B financing in Exciva, a clinical-stage biopharmaceutical company developing treatments for behavioral symptoms associated with Alzheimer’s disease, with proceeds earmarked to move ... |
| 13.01.2026 | Kinaset Therapeutics Secures $103M for Severe Asthma Drug Advancement | Kinaset Therapeutics obtained $103 million in Series B funding. This capital fuels the development of frevecitinib. Frevecitinib is an innovative inhaled pan-JAK inhibitor. It targets severe asthma and other serious respiratory diseases. Th... |
| 12.01.2026 | Kinaset Therapeutics Raises $103M in Series B Funding | Kinaset Therapeutics, a Boston, MA-based clinical-stage biopharmaceutical company, raised $103M in Series B funding.
The round was led by RA Capital Management and Forge Life Science Partners, with participation from new investors EQT Life ... |
| 12.01.2026 | EQT Life Sciences backs Kinaset Therapeutics’ USD103 million Series B to advance inhaled therapeutic for treatment of respiratory diseases | EQT Life Sciences backs Kinaset Therapeutics’ USD103 million Series B to advance inhaled therapeutic for treatment of respiratory diseases
Mon, Jan 12, 2026 13:00 CET Report this content
EQT Life Sciences invests in U.S.-based Kinaset Thera... |
| 10.01.2026 | Kinaset Therapeutics: $103 Million Series B Closed To Advance Inhaled Pan-JAK Drug For Severe Asthma | Kinaset Therapeutics, a clinical-stage biopharmaceutical company focused on developing inhaled therapies for severe respiratory diseases, announced it has closed a $103 million oversubscribed Series B financing to fund mid-stage development... |
| 22.10.2025 | EQT Life Sciences’ ImCheck Therapeutics to be acquired by Ipsen in a transaction valued at up to EUR 1 billion | EQT Life Sciences’ ImCheck Therapeutics to be acquired by Ipsen in a transaction valued at up to EUR 1 billion
Wed, Oct 22, 2025 09:20 CET Report this content
Ipsen and ImCheck Therapeutics have entered into a definitive share purchase agre... |
| 01.10.2025 | Spineart secures CHF 25M investment to boost global growth |
Spineart’s growth strategy is anchored in a portfolio of cutting-edge technologies designed to make spine surgery safer, more efficient and effective. With a strong focus on clinical outcomes, the company is expanding across Europe and the... |
| 01.10.2025 | Spineart secures CHF 25M investment to boost global growth |
Spineart’s growth strategy is anchored in a portfolio of cutting-edge technologies designed to make spine surgery safer, more efficient and effective. With a strong focus on clinical outcomes, the company is expanding across Europe and the... |
| 11.02.2025 | Junction Growth Investors: A New Dawn for Europe's Energy Transition | In the heart of Antwerp, a financial revolution is brewing. Junction Growth Investors has successfully closed its inaugural fund at €115 million, surpassing its initial target of €100 million. This is not just a number; it’s a beacon of hop... |
| 11.02.2025 | Junction Growth Investors closes first Fund at €115M | Junction Growth Investors has closed its first fund at €115 million.
The Belgium firm was founded in the summer of 2022 by a group of award-winning entrepreneurs, CEOs Bruno Vanderschueren (ex-Lampiris) and Pieter-Jan Mermans (ex-REstore), ... |
| 09.01.2025 | FIRE1: $120 Million Funding Raised For Transforming Heart Failure Care | FIRE1 – a leading connected medical device solutions company – announced the completion of a $120 million financing round to accelerate the company’s mission to transform the lives of millions of people living with heart failure. The fundin... |
| 08.01.2025 | FIRE1 Secures $120M for Heart Failure Management Platform | What You Should Know:
– FIRE1, a connected medical device company, announced it has secured $120M in funding to advance its mission to transform the lives of millions of people living with heart failure. The round was led by Polaris Partner... |
| 07.01.2025 | FIRE1 Secures $120M Financing | FIRE1, a Dublin, Ireland-based connected medical device solutions company, raised $120M in funding.
The round was led by Polaris Partners and Elevage Medical Technologies, joined by new investors Sands Capital and Longitude Capital, and exi... |
| 07.01.2025 | FIRE1 heats up with $120M for its heart failure monitor implant | Things are heating up for FIRE1, which posted a $120 million funding round to support its implant for tracking the hidden signs of heart failure.
The Dublin-based company also announced that the FDA has handed down a breakthrough designatio... |
| 18.09.2024 | Immunos Therapeutics raises USD11 million |
ImmunOs’ lead program IOS-1002 is currently tested in a Phase Ia dose escalation clinical trial as a monotherapy and in combination with MSD’s anti-PD-1 therapy KEYTRUDA (pembrolizumab). IOS-1002 is a novel, multifunctional immunotherapy a... |
| 16.04.2024 | After raising €15M, Amsterdam’s Silverflow announces new supervisory board to accelerate growth | Read this article in:
Amsterdam-based Silverflow, a cloud platform for global card processing, announced on Tuesday that its executive leadership team will receive strategic support from a new supervisory board.
The announcement follows the... |
| 16.08.2023 | Arcus acquires Coolworld Investments B.V. | Leading European industrial temperature control equipment rental specialist Coolworld to be sold by Gimv to Arcus European Infrastructure Fund 3, the third fund of Arcus Infrastructure Partners |
| 01.06.2023 | ERS electronic Welcomes New Investor, European private equity firm Gimv, on Board to Accelerate Scaling Efforts | MUNICH, June 1, 2023 /PRNewswire/ -- ERS electronic GmbH, the industry leader in the market of thermal management solutions for semiconductor manufacturing, is pleased to announce the addition of a new investor, Gimv, a Belgian private equi... |
| 11.05.2023 | Il mercato del Venture Capital ad aprile 2023 | Come è andato il mercato del Venture Capital ad aprile 2023? Facciamo insieme una carrellata delle startup, delle scaleup e dei round più interessanti. Purtroppo, i dati del primo trimestre 2023 confermano i trend negativi in Europa per gli... |
| 02.02.2023 | The week in agrifoodtech: Plant-based salmon reels in $12m, new funding for ag robots, Impossible layoffs | This week, Canada’s New School Foods snagged seed funding for its whole-cut plant-based salmon. In agtech, BloomX secured funding for its pollination tech and E-Terry for its farm robot. Meanwhile, KFC struck a deal to put robots in its kit... |
| 11.11.2022 | This Week in European Tech: EQT closes €1.1 billion fund, crypto payments firm Ramp nabs $70 million, Meta buys Audio Analytic, and more
24 May in Brussels.
What happened this week in European Tech?... | This week, our research team tracked 100 tech funding deals worth over €1 billion, and over 20 exits, M&A transactions, rumours, and related news stories across Europe.
As always, we are putting all of them together for you in a list se... |
| 07.06.2022 | ImmunOs Therapeutics raises $74 Million to fund clinical trials | |
| 14.01.2022 | Gimv : Arseus Medical Group announces new partnership with Heart Medical Europe BV | Heart Medical Europe BV is a distributor of interventional (paediatric) cardiology, interventional radiology and cardio-thoracic surgery products in the Benelux. As a Belgian top player and reference in the distribution of medical and param... |
| 23.12.2021 | Gimv : Interview VFB with Kristof Vande Capelle and Tom Van de Voorde | Kristof Vande Capelle - CFO and Tom Van de Voorde - Head Smart Industries - talked to the Vlaamse Federatie van Beleggers - VFB about our investment strategy and the way we want to help companies scale up and create value as a partner. Read... |
| 16.09.2021 | Anjarium Biosciences Raises CHF 55.5 Million Series A Financing | |
| 29.07.2021 | Gimv : Topas Therapeutics announces and extended Series B round with an additional 18 million (~$ 22 million) | Funds to be used to obtain clinical proof of concept in two programs and to accelerate innovative pipeline focused on restoring immune tolerance to treat and potentially cure autoimmune diseases
Initial clinical data for lead program, TPM20... |
| 29.07.2021 | Gimv : Topas Therapeutics announces and extended Series B round with an additional 18 million (± $ 22 million) | Funds to be used to obtain clinical proof of concept in two programs and to accelerate innovative pipeline focused on restoring immune tolerance to treat and potentially cure autoimmune diseases
Initial clinical data for lead program, TPM20... |
| 29.07.2021 | Gimv : Topas Therapeutics announced and extended Series B round with an additional 18 million (~$ 22 million) | Funds to be used to obtain clinical proof of concept in two programs and to accelerate innovative pipeline focused on restoring immune tolerance to treat and potentially cure autoimmune diseases
Initial clinical data for lead program, TPM20... |
| 27.07.2021 | Gimv : The Grandeco Wallfashion Group further expands its business in wall decoration through the integration of Wall!Supply and grows to a turnover of 100 million euros | Tielt, July 23, 2021 - Grandeco Wallfashion Group is pleased to announce the acquisition of the entire shareholder capital of Wall!Supply, the market leader in decorative 3D panels. Following the acquisition of Holden Decor in 2020, this ac... |
| 05.07.2021 | Gimv : Biotalys announces successful 54.6 million Initial Public Offering | Ghent, BELGIUM - 01 July 2021 - Biotalys NV ('Biotalys' or the 'Company') an Agricultural Technology (AgTech) company focused on addressing food protection challenges with protein-based biocontrol solutions for a more sustainable and safer ... |
| 01.07.2021 | Gimv : Cross and Gimv form European market leader for wire mesh solutions | The German WDM Group, a leading supplier of customised, spot-welded wire mesh solutions, and the German Deutenberg Group, a producer of high-quality bent wire components, join forces
The partnership will reinforce the market leadership in t... |
| 01.06.2021 | GIMV NV
Gimv : Incendin reaches breakthrough in sustainable technology for fire safety | New formulation of fluorine-free additives for portable fire extinguishers warrants lifesaving performance, without the environmental cost
Tisselt, Belgium, 1 June 2021 - As governments around the world continue to ban the use of firefighti... |
| 23.04.2021 | Fresh capital for ONWARD to tackle spinal cord injuries | |
| 23.04.2021 | Fresh capital for ONWARD to tackle spinal code injuries | ONWARD’s ARC therapy can be delivered by an implantable system called ARC-IM and an external system called ARC-EX. Both platforms are designed to deliver targeted, programmed stimulation of the spinal cord to restore movement, independence,... |
| 19.11.2020 | SynOx Therapeutics raises €37M in Series A Financing | DUBLIN, Nov. 19, 2020 /PRNewswire/ — SynOx Therapeutics Ltd (“SynOx”), a clinical stage bio pharmaceutical company, announces today the closing of a €37 million Series A financing co-led by HealthCap and Medicxi and joined by investors Forb... |
| 15.09.2020 | GIMV NV
Gimv : ImCheck Announces Investment by BB Pureos Bioventures to Close Series B Fundraising with Total of 54 million ($64 million) | Marseille, France, September 15, 2020 - ImCheck Therapeutics today announced that it has secured an additional €6 million ($7.1 million) from BB Pureos Bioventures ('Pureos') in an extension of its Series B bringing the total raised in this... |
| 29.06.2020 | D2E sells stake in Contraload | Gimv, D2E and founders sell logistics service provider Contraload to Tosca, an American player in reusable packagings and supply chain solutions |
| 12.06.2020 | EGS Beteiligungen invests CHF 50 million in Spineart | Spineart was co-founded in 2005 by Jérome Levieux and Stéphane Mugnier-Jacob, who both have over 20 years’ experience in the spine industry and co-lead Spineart. Over the past 4 years, Geneva-based Spineart has doubled its sales to reach a ... |
| 12.06.2020 | EGS Beteiligungen invests CHF 50 million in Spineart | |
| 20.03.2020 | D2E invests in Grandeco | Press Release – Antwerp |
| 12.06.2018 | Dutch company One of a Kind sells a majority stake to Gimv for more than €5 million | One of a Kind Technologies has raised a funding round from the Belgium-headquartered investment firm Gimv in exchange for a majority stake. The parties have not disclosed the valuation and funding amount, but the latter number exceeded €5 m... |
| 31.03.2017 | Gimv and Management Take Over ALT Technologies from Standard Investment | Gimv, along with the management of the company, is taking over ALT Technologies, a Dutch producer of key airbag components, from Standard Investment, which has held a majority stake since 2011.
The private equity firm is acquiring a 67% sta... |
| 05.10.2016 | Gimv invests in Acceo | Private equity firm Gimv has acquired a majority stake in Acceo, a French provider of inspection and certification services for buildings.
The amount of the deal was not disclosed.
Gimv invested in the company next to founder/CEO Stéphane D... |
| 29.09.2016 | Agtech Funding Sheet: FreshDirect to Expand with $189m PE Deal, European and Argentinian Startups Raise, more | Top funding
FreshDirect, one of the first online grocery delivery services ever, has raised $189 million in private equity capital, 14 years since launching. J.P. Morgan Asset Management led the round, with participation from direct seconda... |
| 20.09.2016 | Spineart announces a EUR 30 million investment | |
| 09.05.2016 | Arplas Systems Raises €10M in Equity Funding | Arplas Systems, an Amersfoort, the Netherlands-based provider of resistance projection welding solutions, raised €10m in equity funding.
With the investment, Gimv acquired a majority stake in the company, next to the management who will rem... |
| 28.04.2016 | Joolz Receives Private Equity Investment from Gimv | Joolz, an Amsterdam, The Netherlands-based pushchair brand, received a private equity investment of undisclosed amount from Gimv.
With the deal, which is still subject to customary closing conditions, the investor is acquiring a 40% stake i... |
| 19.04.2016 | G-Therapeutics raises EUR 36 million | |
| 08.01.2016 | Groupe Legallais Receives Minority Investment from Gimv | Groupe Legallais, a French distributor of ironmongery, received a minority investment from private equity firm Gimv.
The deal, whose amount was not disclosed, remains subject to customary closing conditions, including approval by the compet... |
| 03.11.2015 | Equipe Zorgbedrijven Receives €12.5M Private Equity Investment from Gimv | Equipe Zorgbedrijven, an independent group of specialized clinics on 11 locations throughout the Netherlands, received a €12.5m private equity investment.
Gimv made the investment in exchange of a minority stake in the company (The transact... |
| 10.09.2015 | Daily funding roundup - September 10, 2015 | HookLogic landed $15.5M; Fundbox nabbed $50M; Biom'Up raised $35.1M
HookLogic, a company that partners with retailers and online travel agencies to accelerate sales for product brands and hotels in order to give them access to in-market sho... |
| 07.08.2015 | Daily funding roundup - August 7, 2015 | JenaValve completed $26.5M; Dinner Lab raised $7M: Lemonade Lab secured $5.8M
Rebagg, a frictionless luxury resale service, announced the close of a $4.0 Million Seed round of funding led by General Catalyst. Metamorphic Ventures, Crosslink... |
| 25.11.2014 | Melijoe.com Completes €9M Funding Round | Melijoe.com, a Paris, France-based children’s multi-brand fashion e-tailer, completed a €9m funding round.
The round was led by Gimv, with participation from existing shareholder CM-CIC Capital Privé.
The company intends to use the funds to... |
| 10.12.2013 | Covagen Secures CHF42M in Series B Financing | Covagen, a Swiss preclinical-stage biotech company, secured CHF42m in Series B financing.
The round was led by new investor Gimv (with CHF 8.3m) with participation of new investor Ascent Biomedical Ventures and existing investors Novartis V... |
| 09.12.2013 | Covagen Secures CHF 42 Million in Series B Financing | |
| 05.12.2013 | Eurocept Receives Minority Investment from GIMV | Eurocept, an Ankeveen, the Netherlands-based healthcare company, received a minority investment of undisclosed amount.
Gimv and the Gimv Health & Care Fund made the investment, which will be subject to the necessary approval of the Dutc... |
| 27.11.2013 | Endosense closes CHF 37.4 million series C round | |
| 26.06.2013 | Complix Closes €12M Series B Equity Financing | Complix, a Hasselt (Belgium)-based biopharmaceutical company focused on the discovery and development of a class of protein therapeutics active against intracellular disease targets, closed a €12m (approximately US$15.5m) Series B equity fi... |
| 21.06.2013 | Planetveo Raises €15M in Funding | Planetveo, a Paris, France-based on-line travel agency specialized in tailormade, long-haul holiday packages, raised €15m in funding.
Backers included Gimv and Iris Capital, which are investing equally.
The company intends to use the funds ... |
| 28.02.2013 | Gimv Launches Health & Care Fund | Private equity firm Gimv has just launched a fund which will focus on growth companies in the Health & Care Services and Medtech sectors.
Gimv’s initial investment amounts to €50m was matched by the Flemish Government, which is also com... |
| 11.02.2013 | Multiplicom Raises €5.5M | Multiplicom NV, a Niel, Belgium-based company that specializes in molecular diagnostics, raised €5.5m in funding.
Backers included Flemish investment company PMV, RMM and Qbic ARKIV Fund and existing investors Gimv (Biotech Fonds Vlaanderen... |
| 11.01.2013 | AgroSavfe Receives €5M in Funding | AgroSavfe, a Gent, Belgium-based green biotech company, recently received €5m in funding.
Backers included Gimv, which invested €2m via the Gimv-Agri+ Investment Fund, and VIB, Sofi, PMV, QBIC and some other venture capitalists, which inves... |
| 06.09.2012 | GOVECS Raises €10M in Financing | GOVECS GmbH, a Munich, Germany-based electric scooter company, has raised €10m in financing.
The round was led by Gimv, which invested €4m, with participation from KfW, BayBG and other (unnamed) existing shareholders.
The company intends to... |
| 31.07.2012 | ARS T&TT Receives Minority Investment from Gimv | ARS T&TT, a The Hague, The Netherlands-based provider of solutions for Intelligent Transport Systems, has received a minority equity investment of undisclosed amount from Gimv.
Gimv, which has acquired a 25% stake, intends to help the c... |
| 24.05.2012 | Prosonix Raised £17.1M in Series B Equity Financing | Prosonix, a Oxford, UK-based specialty pharma company developing novel respiratory medicines, has held the second closing of a £17.1m Series B equity financing round.
Backers include Gimv, which invested £5.7m, Ventech, Gilde Healthcare Par... |
| 21.03.2012 | NovoPolymers Raises €5.4M in Equity Funding | NovoPolymers NV, a Puurs, Belgium-based company specialized in the design and conversion of polymer formulations into photovoltaic encapsulant sheets, has raised €5.4m in equity funding.
Backers include existing investors Gimv, Capricorn Cl... |
| 08.03.2012 | GreenWatt Raises €6M in Funding | GreenWatt, a Louvain-la-Neuve, Belgium-based waste-to-energy company, has raised €6m in funding.
The round was led by Gimv-Agri+, which committed €3.6m, with participation from new investors Innogy Venture Capital and SRIW, and existing inv... |
| 26.02.2012 | Oldelft Ultrasound Receives Majority Investment from Gimv | Oldelft Ultrasound, a Delft, The Netherlands-based medical diagnostic company, has received a a majority investment from Gimv.
The amount of the transaction remained undisclosed.
Gimv, which invested alongside the existing management team o... |
| 03.01.2012 | Gimv re-invests in VCST | European Investment company Gimv has re-invested in VCST, a Sint-Truiden, Belgium-based developer and producer of precision parts for engine and transmission gears, transmission shafts and brake components, for both automotive and non-autom... |
| 08.11.2011 | Tinubu Square Raises €11.3M in Funding | Tinubu Square, a Paris, France-based cloud technology company for the trade credit industry, has raised €11.3m in funding.
Backers include the Fonds Stratégique d’Investissement (FSI) and the company’s founding shareholders.
Existing invest... |
| 14.10.2011 | Walkro International Acquired by Monaghan Mushrooms and Gimv | Walkro International, a Belgium-based producer of mushroom substrate, has been acquired by Monaghan Mushrooms and Gimv.
Following the transaction, which is still subject to clearance from the relevant competition authorities and is expected... |
| 07.10.2011 | Trustteam Receives Majority Investment from Gimv | Trustteam, a Kortrijk, Belgium-based ICT company offering total solutions to SMEs with regard to infrastructure, software, security and communication, has received a majority investment of undisclosed amount from Gimv.
Following the close o... |
| 19.09.2011 | Email banking company ActivePath raises $10M | The company's interactive email solution allows consumers to make bank transactions via email
Banking-by-email company ActivePath announced Monday that it has raised $10 million in a Series B round of funding led by Battery Ventures and Gim... |
| 19.09.2011 | ActivePath Raises $10M in Funding | ActivePath, a New York-based developer of interactive email and messaging solutions, has raised $10m in funding.
The round was led by Battery Ventures and Gimv NV, with participation from existing investors including Genesis Partners.
The c... |
| 31.08.2011 | Ebuzzing Raises $24.5M in Second Funding | Ebuzzing, formerly Wikio Group, a European social media group, has raised $24.5m in second funding round.
The round was led by Gimv, which is injecting $14.5m, with participation from existing shareholders Lightspeed, Gemini, Solorun and th... |
| 31.08.2011 | Ebuzzing Secures $25m To Expand European Social Marketing Platform | Wikio Group, best known for operating the Wikio news engine, has secured $25 million in financing from investors and is changing its name to ebuzzing, an existing product in its portfolio.
Gimv, one of the main investment companies in Europ... |
| 31.08.2011 | Social marketing company Ebuzzing bags $25M | The European company gets help from Gimv
Ebuzzing, a European social marketing company formerly known as Wikio Group, announced Wednesday a $25 million second round of funding, with European investment firm Gimv leading the round with $14.5... |
| 26.08.2011 | Studiekring Receives Majority Equity Investment from Gimv | Studiekring, a Utrecht, the Netherlands-based provider of tutoring for primary and secondary students, has received a majority equity investment of undisclosed amount from Gimv.
Besides acquiring existing shares, Gimv is also providing capi... |
| 01.08.2011 | XL Video Receives €19M Investment from Gimv | XL Video, an Ostend-belgim-based global player in the rental of video display systems for concerts, shows and other events, has received a €19m investment from the Gimv-XL fund.
Following the transaction, which consists of both a capital in... |
| 19.07.2011 | CCN Group Acquired by Halder | CCN Group, a Thyez, France-based manufacturer of high precision components used in turbochargers for automotive engines, has been acquired by Halder through an MBO.
Sellers include industrial private equity fund Helarb Fund who had taken ov... |
| 06.07.2011 | In a historic move, 21 European investors agree on standard term sheet for startups | Reviewing term sheets from investors can be time consuming and not a little confusing, especially for first time entrepreneurs who may have never seen one before. That puts them at a disadvantage against the investor. Across Europe, the pic... |
| 17.01.2011 | The Brunel Group Receives Equity Investment to Execute MBO | The Brunel Group, a Lille, France-based manufacturer of high quality household cleaning products, has received an equity investment of undisclosed amount from Azulis Capital and Gimv.
Along with BNP Paribas Développement, Synergie Finance a... |
| 29.10.2010 | What you need to know - Friday 10/29/10 | Buddy Media raised $5 million; Nomadesk raised $7M; Facebook releases friendship pages
The CEO of YouTube is stepping down. Chad Hurley, who was also one of the founders of the site, has been transitioning out of the role for some time now.... |
| 29.10.2010 | Funding roundup - week ending 10/29/10 | Appcelerator, Appmakr, BirchBox, Buddy Media, Kiip, Nomadesk, Spotlight, TxVIA, Zuberance
From the seed-stage to the late-stage, here are the most notable startup companies to raise new funding in the past week.
Appcelerator, an open source... |
| 29.10.2010 | Nomadesk takes home $7M in B Series funding | The cloud computing company is backed by new investor BAMS Angel Fund and previous backer Gimv
Belgian cloud computing company Nomadesk announced Friday morning that it has raised $7 million (or €5 million) in a Series B round led by new in... |
| 21.09.2010 | Belgian VC Gimv drops 4.9 million euros on Vente-Privée competitor Private Outlet | After investing some 15 million euros in France-based OneDirect a few weeks ago, Belgian VC fund Gimv has just announced that it is dropping 4.9 million euros on a Vente-Privée competitor called Private Outlet. This investments brings the c... |
| 06.09.2010 | Onedirect Receives €15M Investment from Gimv | Onedirect, a Saint Estève, France-based e-commerce company which specializes in the sale of leading brands in professional telephony, has received a €15m investment from Gimv.
With this investment, which is part of the management buyout of ... |
| 03.09.2010 | Belgium's Gimv puts 15 million euros into Onedirect | Belgium’s Gimv – the investment firm that is behind companies like Inside Contactless, Openbravo and Telenet – has just put some 15 million euros into Onedirect, which specializes in e-commerce for B2B telephone devices and solutions. The f... |
| 25.05.2010 | European VC deals of the week | These are the latest VC deals happening around Europe that we’ve unearthed. Germany is still going strong, but France and Spain are keeping up pretty well.
High-Tech Gründerfonds has led an investment in software developer Propertybase GmbH... |
| 28.04.2010 | Gimv invests €4.7m in workspace management company RES Software | [Netherlands] RES Software, which offers workspace management software and services, has secured a €4.7 million investment from the publicly traded European private equity and VC firm Gimv.
Having recently appointed a new CEO and seen ‘sign... |
| 28.04.2010 | Res Software Raises €4.7M | RES Software, a ‘s-Hertogenbosch, The Netherlands- and Plymouth Meeting, PA-based user workspace management software company, closed a €4.7m (approximately $6.3m) equity financing.
The investment was led by Gimv, a publicly traded European ... |
| 16.03.2010 | Gimv Closes €609M Private Equity Fund | Gimv, an Euronext, Brussels-listed investment company which specialises in private equity and venture capital, announced the successful final closing of the Gimv-XL fund at €609m.
The fund, which started business in January 2009 with €500m,... |
| 20.12.2009 | Nomadesk, Not Just Another File Sharing Service, Launches FolderLink (Video) | The hundreds of web and desktop clients built for sharing, backup or on-the-fly synchronization of digital files that have sprung up in the past ten years have made the whole concept of having the cloud at least partly remove your computer ... |
| 30.07.2009 | Pain treatment maker TorreyPines saved by Raptor merger | TorreyPines Therapeutics, maker of pain management medication, has skirted failure through a $1.4 million merger deal with Raptor Therapeutics. The deal dictates that Raptor will become a full subsidiary of TorreyPines, which is publicly tr... |
